Prescription omega-3-acid ethyl esters reduce fasting and postprandial triglycerides and modestly reduce pancreatic b-cell re- sponse in subjects with primary hypertriglyceridemia. Prostaglandins Leukot Essent Fatty Acids. 2011;85:143-148.Maki KC, Lawless AL, Kelley KM, Dicklin MR, Schild AL, Rains...
A viable pharmacological option includes prescription omega-3 (P-OM3) fatty acid ethyl esters. Each 4-g/d dose of P-OM3 provides 465 mg of eicosapentaenoic acid and 375 mg of docosahexaenoic acid. Clinical trials show that P-OM3 can safely and effectively decrease TGs by 45% in patients ...
A prescription combination of omega-3-acid ethyl esters (P-OM3; Lovaza™ Capsules, Reliant Pharmaceuticals, Inc.) is available that contains concentrated forms of EPA (~465 mg), DHA (~375 mg) and other omega-3 fatty acids (~60 mg), for a total of at least 900 mg of omega-3 ...
Reiner Z. Combination therapy with prescription omega-3acid ethyl esters and statin improves non-HDL-C more effectively than statin alone. Clin Lipidol, 2010; 5: 325-328.Reiner Z. Combination therapy with prescription omega-3- acid ethyl esters and statins improves non-HDL-C more effectively ...
BRUNTON S, COLLINS N: Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids. Curr Med Res Opin 23: 1139-1145, 2007.Brunton S., Collins N. 2007. Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-...
Rupp H. Omacor (Prescription omega-3 acid ethyl esters 90): from severe rhythm disorders to hypertriglyceridemia. Adv Ther. 2009;26: 675-90.Rupp H. Omacor (prescription omega-3-acid ethyl esters 90): From se- vere rhythm disorders to hypertriglyceridemia. Adv Ther. 2009; 26(7):675-90....
effects of prescription omega-3-acid ethyl estersBays
Prescription omega-3-acid ethyl esters reduce fasting and postprandial triglycerides and modestly reduce pancreatic b-cell re- sponse in subjects with primary hypertriglyceridemia. Prostaglandins Leukot Essent Fatty Acids. 2011;85:143-148.Maki KC, Lawless AL, Kelley KM, Dicklin MR, Schild AL, Rains...
Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: A prospective study. Am Heart J. 2009; 158 :163–169. e161-163.Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic ...
This study assessed whether the addition of prescription omega-3-acid ethyl esters (P-OM3) to stable statin therapy can further improve non-HDL-C and other lipid variables in subjects with persistent hypertriglyceridemia. Multicenter, randomized, double-blind, placebo-controlled. 8-week lead-in ...